Table 1.
Characteristics of Women at the Indication for a Statin
| HIV-seropositive (N = 321) | HIV-seronegative (N = 150) | |||
|---|---|---|---|---|
| Characteristic | Median (IQR) | n (%) | Median (IQR) | n (%) |
| Age (years) | 45 (39, 50) | 43 (35, 48) | ||
| Race | ||||
| Black | 187 (58) | 92 (61) | ||
| White | 83 (26) | 23 (15) | ||
| Other | 51 (16) | 35 (23) | ||
| Education | ||||
| <12 years | 111 (35) | 55 (37) | ||
| 12 years | 94 (29) | 47 (31) | ||
| >12 years | 116 (36) | 48 (32) | ||
| Smoking | 142 (44) | 95 (63) | ||
| Hypertension | 156 (49) | 71 (47) | ||
| LDL cholesterol (mg/dL) | 165 (143, 190) | 160 (142, 178) | ||
| HDL cholesterol (mg/dL) | 45 (36, 55) | 46 (39, 55) | ||
| Triglycerides (mg/dL) | 160 (113, 224) | 130 (96, 177) | ||
| CD4 cell count | 490 (326, 682) | |||
| Log10 HIV RNA | 2.3 (2.3, 3.2) | |||
| ART use | 275 (86) | |||
| AIDS diagnosis | 140 (44) | |||
ART, antiretroviral therapy; HDL, high-density lipoprotein; IQR, interquartile range; LDL, low-density lipoprotein; RNA, ribonucleic acid.